Antares Therapeutics

Boston, MA · Founded 2025 · Privately Held (backing)

Operator of a biotechnology company intended to develop first-in-class precision medicines targeting previously undruggable cancer and serious disease targets. Antares Therapeutics is based in Boston, MA and was founded in 2025. It is valued at about $299 million as of Oct 2026, set by institutional fund marks. It has raised $177 million across 2 recorded rounds; the latest was a $30 million early-stage round in May 2025.

PMV mark · valuation
$299.0M
Oct 2026
Priced at
its early-stage round
Apr 2025
Total raised
$177.0M
Last round
Early Stage VC
May 2025
How much has Antares Therapeutics raised?
$177.0Macross 2 recorded rounds · Mar 2025 – May 2025

Most recently, Antares Therapeutics raised $30.0M in its Early Stage VC (May 2025).

Free account
More of Antares Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Antares Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Antares Therapeutics round by round

2 rounds
May 2025Early Stage VC$30.0MSEC filing▮
35 investors participated
Mar 2025Early Stage VC$40.0MSEC filing▮
3 investors participated

How much has Antares Therapeutics raised?

Antares Therapeutics has raised $177 million in total; 2 of its rounds are on record. The largest on record was a $40 million early-stage round in Mar 2025; the most recent was a $30 million early-stage round in May 2025.

Antares Therapeutics has filed 2 Form Ds with the SEC, most recently in May 2025 ($30 million sold to 35 investors).

Antares Therapeutics investors

11 investors are on record for Antares Therapeutics, including Lightspeed Venture Partners, Cormorant Asset Management, Invus Opportunities and Omega Funds. By type, the record holds 3 venture capital firms, 1 family office and 1 private equity firm. The early-stage round in May 2025 drew 35 investors.

For fundraisers
Raising for a company like Antares Therapeutics?

11 investors have backed Antares Therapeutics.

See all 11 investors →

Frequently asked about Antares Therapeutics

How much has Antares Therapeutics raised?
Antares Therapeutics has raised $177.0M in total across 2 recorded funding rounds.
When was Antares Therapeutics's last funding round?
Antares Therapeutics's most recent recorded round was Early Stage VC in May 2025, raising $30.0M.